Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 373 to 380 of 380 entries
Sorted by: Best Match Show Resources per page
Can You Activate Me? From Robots to Human Brain.

Frontiers in robotics and AI

Manzi F, Di Dio C, Di Lernia D, Rossignoli D, Maggioni MA, Massaro D, Marchetti A, Riva G.
PMID: 33681301
Front Robot AI. 2021 Feb 19;8:633514. doi: 10.3389/frobt.2021.633514. eCollection 2021.

No abstract available.

Cite
Manzi F, Di Dio C, Di Lernia D, et al. Can You Activate Me? From Robots to Human Brain. Front Robot AI. 2021;8:633514doi: 10.3389/frobt.2021.633514.
Manzi, F., Di Dio, C., Di Lernia, D., Rossignoli, D., Maggioni, M. A., Massaro, D., Marchetti, A., & Riva, G. (2021). Can You Activate Me? From Robots to Human Brain. Frontiers in robotics and AI, 8633514. https://doi.org/10.3389/frobt.2021.633514
Manzi, F, et al. "Can You Activate Me? From Robots to Human Brain." Frontiers in robotics and AI vol. 8 (2021): 633514. doi: https://doi.org/10.3389/frobt.2021.633514
Manzi F, Di Dio C, Di Lernia D, Rossignoli D, Maggioni MA, Massaro D, Marchetti A, Riva G. Can You Activate Me? From Robots to Human Brain. Front Robot AI. 2021 Feb 19;8:633514. doi: 10.3389/frobt.2021.633514. eCollection 2021. PMID: 33681301; PMCID: PMC7933445.
Copy Download .nbib Format: NLM
Single-Cells Isolation and Molecular Analysis: Focus on HER2-Low CTCs in Metastatic Breast Cancer.

Cancers

D'Amico P, Reduzzi C, Qiang W, Zhang Y, Gerratana L, Zhang Q, Davis AA, Shah AN, Manai M, Curigliano G, Cristofanilli M.
PMID: 35008244
Cancers (Basel). 2021 Dec 24;14(1). doi: 10.3390/cancers14010079.

Although the detection of CTCs expressing HER2 at low intensity (HER2-low CTCs) has been shown to have a negative prognostic value in metastatic breast cancer (MBC) patients, the biological intrinsic nature of HER2-low CTCs remains unexplored. Considering the technical...

Cite
D'Amico P, Reduzzi C, Qiang W, et al. Single-Cells Isolation and Molecular Analysis: Focus on HER2-Low CTCs in Metastatic Breast Cancer. Cancers (Basel). 2021;14(1)doi: 10.3390/cancers14010079.
D'Amico, P., Reduzzi, C., Qiang, W., Zhang, Y., Gerratana, L., Zhang, Q., Davis, A. A., Shah, A. N., Manai, M., Curigliano, G., & Cristofanilli, M. (2021). Single-Cells Isolation and Molecular Analysis: Focus on HER2-Low CTCs in Metastatic Breast Cancer. Cancers, 14(1), . https://doi.org/10.3390/cancers14010079
D'Amico, Paolo, et al. "Single-Cells Isolation and Molecular Analysis: Focus on HER2-Low CTCs in Metastatic Breast Cancer." Cancers vol. 14,1 (2021). doi: https://doi.org/10.3390/cancers14010079
D'Amico P, Reduzzi C, Qiang W, Zhang Y, Gerratana L, Zhang Q, Davis AA, Shah AN, Manai M, Curigliano G, Cristofanilli M. Single-Cells Isolation and Molecular Analysis: Focus on HER2-Low CTCs in Metastatic Breast Cancer. Cancers (Basel). 2021 Dec 24;14(1). doi: 10.3390/cancers14010079. PMID: 35008244; PMCID: PMC8750036.
Copy Download .nbib Format: NLM
Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries.

Journal of the American Heart Association

Fudim M, Zhong L, Patel KV, Khera R, Abdelmalek MF, Diehl AM, McGarrah RW, Molinger J, Moylan CA, Rao VN, Wegermann K, Neeland IJ, Halm EA, Das SR, Pandey A.
PMID: 34755544
J Am Heart Assoc. 2021 Nov 16;10(22):e021654. doi: 10.1161/JAHA.121.021654. Epub 2021 Nov 10.

Background Nonalcoholic fatty liver disease (NAFLD) and heart failure (HF) are increasing in prevalence. The independent association between NAFLD and downstream risk of HF and HF subtypes (HF with preserved ejection fraction and HF with reduced ejection fraction) is...

Cite
Fudim M, Zhong L, Patel KV, et al. Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries. J Am Heart Assoc. 2021;10(22):e021654doi: 10.1161/JAHA.121.021654.
Fudim, M., Zhong, L., Patel, K. V., Khera, R., Abdelmalek, M. F., Diehl, A. M., McGarrah, R. W., Molinger, J., Moylan, C. A., Rao, V. N., Wegermann, K., Neeland, I. J., Halm, E. A., Das, S. R., & Pandey, A. (2021). Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries. Journal of the American Heart Association, 10(22), e021654. https://doi.org/10.1161/JAHA.121.021654
Fudim, Marat, et al. "Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries." Journal of the American Heart Association vol. 10,22 (2021): e021654. doi: https://doi.org/10.1161/JAHA.121.021654
Fudim M, Zhong L, Patel KV, Khera R, Abdelmalek MF, Diehl AM, McGarrah RW, Molinger J, Moylan CA, Rao VN, Wegermann K, Neeland IJ, Halm EA, Das SR, Pandey A. Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries. J Am Heart Assoc. 2021 Nov 16;10(22):e021654. doi: 10.1161/JAHA.121.021654. Epub 2021 Nov 10. PMID: 34755544; PMCID: PMC8751938.
Copy Download .nbib Format: NLM
Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.

medRxiv : the preprint server for health sciences

Britton GJ, Chen-Liaw A, Cossarini F, Livanos AE, Spindler MP, Plitt T, Eggers J, Mogno I, Gonzalez-Reiche AS, Siu S, Tankelevich M, Grinspan LT, Dixon RE, Jha D, van de Guchte A, Khan Z, Martinez-Delgado G, Amanat F, Hoagland DA, tenOever BR, Dubinsky MC, Merad M, van Bakel H, Krammer F, Bongers G, Mehandru S, Faith JJ.
PMID: 32909002
medRxiv. 2020 Dec 09; doi: 10.1101/2020.09.03.20183947.

We sought to characterize the role of the gastrointestinal immune system in the pathogenesis of the inflammatory response associated with COVID-19. We measured cytokines, inflammatory markers, viral RNA, microbiome composition and antibody responses in stool from a cohort of...

Cite
Britton GJ, Chen-Liaw A, Cossarini F, et al. Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19. medRxiv. 2020;doi: 10.1101/2020.09.03.20183947.
Britton, G. J., Chen-Liaw, A., Cossarini, F., Livanos, A. E., Spindler, M. P., Plitt, T., Eggers, J., Mogno, I., Gonzalez-Reiche, A. S., Siu, S., Tankelevich, M., Grinspan, L. T., Dixon, R. E., Jha, D., van de Guchte, A., Khan, Z., Martinez-Delgado, G., Amanat, F., Hoagland, D. A., tenOever, B. R., Dubinsky, M. C., Merad, M., van Bakel, H., Krammer, F., Bongers, G., Mehandru, S., & Faith, J. J. (2020). Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2020.09.03.20183947
Britton, Graham J, et al. "Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19." medRxiv : the preprint server for health sciences vol. (2020). doi: https://doi.org/10.1101/2020.09.03.20183947
Britton GJ, Chen-Liaw A, Cossarini F, Livanos AE, Spindler MP, Plitt T, Eggers J, Mogno I, Gonzalez-Reiche AS, Siu S, Tankelevich M, Grinspan LT, Dixon RE, Jha D, van de Guchte A, Khan Z, Martinez-Delgado G, Amanat F, Hoagland DA, tenOever BR, Dubinsky MC, Merad M, van Bakel H, Krammer F, Bongers G, Mehandru S, Faith JJ. Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19. medRxiv. 2020 Dec 09; doi: 10.1101/2020.09.03.20183947. PMID: 32909002; PMCID: PMC7480054.
Copy Download .nbib Format: NLM
Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2.

medRxiv : the preprint server for health sciences

Klingler J, Weiss S, Itri V, Liu X, Oguntuyo KY, Stevens C, Ikegame S, Hung CT, Enyindah-Asonye G, Amanat F, Baine I, Arinsburg S, Bandres JC, Kojic EM, Stoever J, Jurczyszak D, Bermudez-Gonzalez M, Nádas A, Liu S, Lee B, Zolla-Pazner S, Hioe CE.
PMID: 33173891
medRxiv. 2020 Dec 21; doi: 10.1101/2020.08.18.20177303.

BACKGROUND: SARS-CoV-2 has infected millions of people globally. Virus infection requires the receptor-binding domain (RBD) of the spike protein. Although studies have demonstrated anti-spike and - RBD antibodies to be protective in animal models, and convalescent plasma as a...

Cite
Klingler J, Weiss S, Itri V, et al. Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2. medRxiv. 2020;doi: 10.1101/2020.08.18.20177303.
Klingler, J., Weiss, S., Itri, V., Liu, X., Oguntuyo, K. Y., Stevens, C., Ikegame, S., Hung, C. T., Enyindah-Asonye, G., Amanat, F., Baine, I., Arinsburg, S., Bandres, J. C., Kojic, E. M., Stoever, J., Jurczyszak, D., Bermudez-Gonzalez, M., Nádas, A., Liu, S., Lee, B., Zolla-Pazner, S., & Hioe, C. E. (2020). Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2020.08.18.20177303
Klingler, Jéromine, et al. "Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2." medRxiv : the preprint server for health sciences vol. (2020). doi: https://doi.org/10.1101/2020.08.18.20177303
Klingler J, Weiss S, Itri V, Liu X, Oguntuyo KY, Stevens C, Ikegame S, Hung CT, Enyindah-Asonye G, Amanat F, Baine I, Arinsburg S, Bandres JC, Kojic EM, Stoever J, Jurczyszak D, Bermudez-Gonzalez M, Nádas A, Liu S, Lee B, Zolla-Pazner S, Hioe CE. Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2. medRxiv. 2020 Dec 21; doi: 10.1101/2020.08.18.20177303. PMID: 33173891; PMCID: PMC7654883.
Copy Download .nbib Format: NLM
Reconstruction of the left atrium for atrial fibrillation ablation using the machine learning CARTO 3 m-FAM software.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing

Schwartz AL, Chorin E, Mann T, M YL, Hochstadt A, Margolis G, Viskin S, Banai S, Rosso R.
PMID: 34382153
J Interv Card Electrophysiol. 2021 Aug 12; doi: 10.1007/s10840-021-01045-4. Epub 2021 Aug 12.

PURPOSE: Atrial fibrillation (AF) ablation requires a precise reconstruction of the left atrium (LA) and pulmonary veins (PV). Model-based FAM (m-FAM) is a novel module recently developed for the CARTO system which applies machine learning techniques to LA reconstruction....

Cite
Schwartz AL, Chorin E, Mann T, et al. Reconstruction of the left atrium for atrial fibrillation ablation using the machine learning CARTO 3 m-FAM software. J Interv Card Electrophysiol. 2021;doi: 10.1007/s10840-021-01045-4.
Schwartz, A. L., Chorin, E., Mann, T., M, Y. L., Hochstadt, A., Margolis, G., Viskin, S., Banai, S., & Rosso, R. (2021). Reconstruction of the left atrium for atrial fibrillation ablation using the machine learning CARTO 3 m-FAM software. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, . https://doi.org/10.1007/s10840-021-01045-4
Schwartz, Arie Lorin, et al. "Reconstruction of the left atrium for atrial fibrillation ablation using the machine learning CARTO 3 m-FAM software." Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing vol. (2021). doi: https://doi.org/10.1007/s10840-021-01045-4
Schwartz AL, Chorin E, Mann T, M YL, Hochstadt A, Margolis G, Viskin S, Banai S, Rosso R. Reconstruction of the left atrium for atrial fibrillation ablation using the machine learning CARTO 3 m-FAM software. J Interv Card Electrophysiol. 2021 Aug 12; doi: 10.1007/s10840-021-01045-4. Epub 2021 Aug 12. PMID: 34382153.
Copy Download .nbib Format: NLM
Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant Recipients.

Frontiers in pediatrics

Nailescu C, Khalid M, Wilson AC, Amanat F, Arregui S, Canas J, Hooks J, Krammer F, Schwaderer AL, Hains DS.
PMID: 33194930
Front Pediatr. 2020 Oct 30;8:601327. doi: 10.3389/fped.2020.601327. eCollection 2020.

No abstract available.

Cite
Nailescu C, Khalid M, Wilson AC, et al. Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant Recipients. Front Pediatr. 2020;8:601327doi: 10.3389/fped.2020.601327.
Nailescu, C., Khalid, M., Wilson, A. C., Amanat, F., Arregui, S., Canas, J., Hooks, J., Krammer, F., Schwaderer, A. L., & Hains, D. S. (2020). Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant Recipients. Frontiers in pediatrics, 8601327. https://doi.org/10.3389/fped.2020.601327
Nailescu, Corina, et al. "Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant Recipients." Frontiers in pediatrics vol. 8 (2020): 601327. doi: https://doi.org/10.3389/fped.2020.601327
Nailescu C, Khalid M, Wilson AC, Amanat F, Arregui S, Canas J, Hooks J, Krammer F, Schwaderer AL, Hains DS. Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant Recipients. Front Pediatr. 2020 Oct 30;8:601327. doi: 10.3389/fped.2020.601327. eCollection 2020. PMID: 33194930; PMCID: PMC7661782.
Copy Download .nbib Format: NLM
Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease.

Hepatology (Baltimore, Md.)

Alexopoulos AS, Crowley MJ, Wang Y, Moylan CA, Guy CD, Henao R, Piercy DL, Seymour KA, Sudan R, Portenier DD, Diehl AM, Coviello AD, Abdelmalek MF.
PMID: 33724511
Hepatology. 2021 Sep;74(3):1220-1233. doi: 10.1002/hep.31806. Epub 2021 Jun 02.

BACKGROUND AND AIMS: Whether glycemic control, as opposed to diabetes status, is associated with the severity of NAFLD is open for study. We aimed to evaluate whether degree of glycemic control in the years preceding liver biopsy predicts the...

Cite
Alexopoulos AS, Crowley MJ, Wang Y, et al. Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease. Hepatology. 2021;74(3):1220-1233doi: 10.1002/hep.31806.
Alexopoulos, A. S., Crowley, M. J., Wang, Y., Moylan, C. A., Guy, C. D., Henao, R., Piercy, D. L., Seymour, K. A., Sudan, R., Portenier, D. D., Diehl, A. M., Coviello, A. D., & Abdelmalek, M. F. (2021). Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease. Hepatology (Baltimore, Md.), 74(3), 1220-1233. https://doi.org/10.1002/hep.31806
Alexopoulos, Anastasia-Stefania, et al. "Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease." Hepatology (Baltimore, Md.) vol. 74,3 (2021): 1220-1233. doi: https://doi.org/10.1002/hep.31806
Alexopoulos AS, Crowley MJ, Wang Y, Moylan CA, Guy CD, Henao R, Piercy DL, Seymour KA, Sudan R, Portenier DD, Diehl AM, Coviello AD, Abdelmalek MF. Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease. Hepatology. 2021 Sep;74(3):1220-1233. doi: 10.1002/hep.31806. Epub 2021 Jun 02. PMID: 33724511; PMCID: PMC8518519.
Copy Download .nbib Format: NLM
Showing 373 to 380 of 380 entries